PATENT CLAIM ANALYSIS

Application Number: 15915774
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["548", "327100"]

Abstract:
Provided is a method for imaging a renal lesion comprising the steps of administrating a nitroimidazole-based compound to a living body and obtaining an image of the renal lesion by detecting radiation non-invasively from the outside of the living body wherein the renal imaging agent comprises a defined nitroimidazole-based compound or a salt thereof. The step of obtaining the image of the renal lesion can include using positron emission tomography.

Claim (Index 3):
The method for imaging a renal lesion according to  claim 1 , wherein the nitroimidazole-based compound is a compound having a log P at 25\u00b0 C. lower than a log P of 1-[ 18 F]fluoro-3-(2-nitro-1H-imidazol-1-yl)-2-propanol.

Metadata:
- Claim Count in Document: 7.0
- Percentile: 90.0
- Lexical Diversity: 1.63636
- Patent Class: 548.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14345493', '15010389', '14945283', '12617721', '14344377']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7210135873603406
- 35 USC 102 Novelty (BERT): 0.4873478596051907
- Combined Prediction Score: 0.6976470145848256
- Mean Citation Score: 155.79453800000005
- Max Citation Score: 164.73218
- Similarity Product: 107.66555183455704

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test